D. E. Shaw & Co., Inc. - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 345 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q2 2023$385,947
-89.1%
5,700
-91.3%
0.00%
-100.0%
Q1 2023$3,528,673
-44.1%
65,225
-42.1%
0.00%
-42.9%
Q2 2022$6,313,000
-83.7%
112,631
-79.4%
0.01%
-80.6%
Q1 2022$38,804,000
-22.9%
545,701
-29.3%
0.04%
-14.3%
Q4 2021$50,345,000
-15.3%
771,457
-2.7%
0.04%
-22.2%
Q3 2021$59,470,000
+47.1%
792,508
+52.9%
0.05%
+54.3%
Q2 2021$40,436,000
+106.3%
518,212
+116.6%
0.04%
+84.2%
Q1 2021$19,597,000
+641.7%
239,286
+648.8%
0.02%
+850.0%
Q4 2020$2,642,000
-71.2%
31,958
-77.4%
0.00%
-77.8%
Q3 2020$9,176,000
+109.9%
141,214
+100.1%
0.01%
+80.0%
Q2 2020$4,371,000
-61.9%
70,569
-60.6%
0.01%
-72.2%
Q1 2020$11,470,000
-55.0%
179,146
-51.3%
0.02%
-37.9%
Q4 2019$25,467,000
-31.9%
367,636
-37.8%
0.03%
-37.0%
Q3 2019$37,395,000
-35.6%
590,937
-35.5%
0.05%
-36.1%
Q2 2019$58,061,000
+9.6%
916,372
+1.0%
0.07%
+5.9%
Q1 2019$52,981,000
+65.8%
907,204
+75.1%
0.07%
+54.5%
Q4 2018$31,962,000
+41.6%
518,024
+78.8%
0.04%
+63.0%
Q3 2018$22,579,000
-20.9%
289,651
-31.3%
0.03%
-27.0%
Q2 2018$28,539,000
+162.3%
421,425
+121.5%
0.04%
+146.7%
Q1 2018$10,879,000190,2890.02%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 400,000$25,612,0009.91%
REINHART PARTNERS, LLC. 687,133$43,997,0004.26%
RK Capital 147,290$9,431,0004.24%
HealthCor Management, L.P. 1,525,809$97,698,0004.18%
Integral Health Asset Management, LLC 115,000$7,363,0003.24%
Sivik Global Healthcare LLC 32,500$7,733,0003.05%
Copeland Capital Management, LLC 635,514$40,692,0002.48%
Rock Springs Capital Management LP 815,000$52,184,0002.16%
Endurant Capital Management LP 55,614$3,561,0001.61%
Advantage Alpha Capital Partners LP 70,005$4,482,0001.60%
View complete list of ENCOMPASS HEALTH CORP shareholders